Regulatory T cells in autologous stem cell transplantation for autoimmune disease

References

• Salomon BL, Sudres M, Cohen JL. Regulatory T cells in graft-versus-host disease. Springer Semin Immunopathol 2006; 28(1)25–29
   PubMedGoogle Scholar
• Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005; 6(4)345–352
   PubMed Web of Science ®Google Scholar
• Katz SI, Parker D, Sommer G, Turk JL. Suppressor cells in normal immunisation as a basic homeostatic phenomenon. Nature 1974; 248(449)612–614
   PubMedGoogle Scholar
• Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155(3)1151–1164
   PubMed Web of Science ®Google Scholar
• Zheng Y, Rudensky AY. Foxp3 in control of the regulatory T cell lineage. Nat Immunol 2007; 8(5)457–462
   PubMed Web of Science ®Google Scholar
• Itoh M, Takahashi T, Sakaguchi N, et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 1999; 162(9)5317–5326
   PubMedGoogle Scholar
• Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 2007; 8(2)191–197
   PubMed Web of Science ®Google Scholar
• von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol 2005; 6(4)338–344
   PubMed Web of Science ®Google Scholar
• Apostolou I, von Boehmer H. In vivo instruction of suppressor commitment in naive T cells. J Exp Med 2004; 199(10)1401–1408
   PubMed Web of Science ®Google Scholar
• Groux H, O'Garra A, Bigler M, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389(6652)737–742
   PubMed Web of Science ®Google Scholar
• Weiner HL. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 2001; 182: 207–214
   PubMed Web of Science ®Google Scholar
• Muraro PA, Douek DC, Packer A, et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 2005; 201(5)805–816
   PubMed Web of Science ®Google Scholar
• van Gelder M, van Bekkum DW. Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation. Bone Marrow Transplant 1996; 18(6)1029–1034
   PubMedGoogle Scholar
• van Bekkum DW. Conditioning regimens for the treatment of experimental arthritis with autologous bone marrow transplantation. Bone Marrow Transplant 2000; 25(4)357–364
   PubMed Web of Science ®Google Scholar
• De Kleer IM, Brinkman DM, Ferster A, et al. Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity. Ann Rheum Dis 2004; 63(10)1318–1326
   PubMed Web of Science ®Google Scholar
• Gratwohl A, Passweg J, Bocelli-Tyndall C, et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 2005; 35(9)869–879
   PubMed Web of Science ®Google Scholar
• Mackall CL, Bare CV, Granger LA, et al. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol 1996; 156(12)4609–4616
   PubMedGoogle Scholar
• Hirota K, Hashimoto M, Yoshitomi H, et al. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med 2007; 204(1)41–47
   PubMed Web of Science ®Google Scholar
• Baccala R, Theofilopoulos AN. The new paradigm of T-cell homeostatic proliferation-induced autoimmunity. Trends Immunol 2005; 26(1)5–8
   PubMedGoogle Scholar
• Theofilopoulos AN, Dummer W, Kono DH. T cell homeostasis and systemic autoimmunity. J Clin Invest 2001; 108(3)335–340
   PubMedGoogle Scholar
• Krupica T, Jr, Fry T J, Mackall CL. Autoimmunity during lymphopenia: A two-hit model. Clin Immunol 2006; 120(2)121–128
   PubMedGoogle Scholar
• Annacker O, Pimenta-Araujo R, Burlen-Defranoux O, et al. CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J Immunol 2001; 166(5)3008–3018
   PubMed Web of Science ®Google Scholar
• Hagen KA, Moses CT, Drasler EF, et al. A role for CD28 in lymphopenia-induced proliferation of CD4 T cells. J Immunol 2004; 173(6)3909–3915
   PubMed Web of Science ®Google Scholar
• Shen S, Ding Y, Tadokoro CE, et al. Control of homeostatic proliferation by regulatory T cells. J Clin Invest 2005; 115(12)3517–3526
   PubMedGoogle Scholar
• Almeida AR, Legrand N, Papiernik M, Freitas AA. Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J Immunol 2002; 169(9)4850–4860
   PubMedGoogle Scholar
• McHugh RS, Shevach EM. Cutting edge: Depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J Immunol 2002; 168(12)5979–5983
   PubMedGoogle Scholar
• Herrmann MM, Gaertner S, Stadelmann C, et al. Tolerance induction by bone marrow transplantation in a multiple sclerosis model. Blood 2005; 106(5)1875–1883
   PubMedGoogle Scholar
• Morgan ME, Flierman R, van Duivenvoorde LM, et al. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum 2005; 52(7)2212–2221
   PubMedGoogle Scholar
• De Kleer I, Vastert B, Klein M, et al. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood 2006; 107(4)1696–1702
   PubMed Web of Science ®Google Scholar
• Gavin MA, Clarke SR, Negrou E, et al. Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat Immunol 2002; 3(1)33–41
   PubMedGoogle Scholar
• Komatsu N, Hori S. Full restoration of peripheral Foxp3+ regulatory T cell pool by radioresistant host cells in scurfy bone marrow chimeras. Proc Natl Acad Sci USA 2007; 104(21)8959–8964
   PubMedGoogle Scholar
• Condomines M, Quittet P, Lu ZY, et al. Functional regulatory T cells are collected in stem cell autografts by mobilization with high-dose cyclophosphamide and granulocyte colony-stimulating factor. J Immunol 2006; 176(11)6631–6639
   PubMedGoogle Scholar
• Curotto de Lafaille MA, Lino AC, Kutchukhidze N, Lafaille JJ. CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion. J Immunol 2004; 173(12)7259–7268
   PubMedGoogle Scholar
• Liang S, Alard P, Zhao Y, et al. Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus. J Exp Med 2005; 201(1)127–137
   PubMed Web of Science ®Google Scholar
• Wan YY, Flavell RA. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci USA 2005; 102(14)5126–5131
   PubMedGoogle Scholar
• Allan SE, Crome SQ, Crellin NK, et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 2007; 19(4)345–354
   PubMed Web of Science ®Google Scholar
• Wang J, Ioan-Facsinay A, van der Voort EI, et al. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 2007; 37(1)129–138
   PubMed Web of Science ®Google Scholar
• Haas J, Fritzsching B, Trubswetter P, et al. Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. J Immunol 2007; 179(2)1322–1330
   PubMed Web of Science ®Google Scholar
• Small TN, Papadopoulos EB, Boulad F, et al. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: Effect of patient age and donor leukocyte infusions. Blood 1999; 93(2)467–480
   PubMedGoogle Scholar
• van Amelsfort JM, Jacobs KM, Bijlsma JW, et al. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 2004; 50(9)2775–2785
   PubMed Web of Science ®Google Scholar
• Ruprecht CR, Gattorno M, Ferlito F, et al. Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J Exp Med 2005; 201(11)1793–1803
   PubMed Web of Science ®Google Scholar
• Feger U, Luther C, Poeschel S, et al. Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients. Clin Exp Immunol 2007; 147(3)412–418
   PubMedGoogle Scholar
• Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441(7090)235–238
   PubMed Web of Science ®Google Scholar
• Pasare C C, Medzhitov R R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003; 299(5609)1033–1036
   PubMedGoogle Scholar
• Valencia X, Stephens G, Goldbach-Mansky R, et al. TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood 2006; 108(1)253–261
   PubMed Web of Science ®Google Scholar
• Korn T, Reddy J, Gao W, et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 2007; 13(4)423–431
   PubMed Web of Science ®Google Scholar
• Szer I, Kimura Y, Malleson P, Southwood T. Arthritis in children & adolescentsFirst Edition. Oxford University Press, New York 2006
   Google Scholar
• Hoffmann P, Eder R, Kunz-Schughart LA, et al. Large-scale in vitro expansion of polyclonal human CD4(+)CD25 high regulatory T cells. Blood 2004; 104(3)895–903
   PubMed Web of Science ®Google Scholar
• Kreijveld E, Koenen HJ, Hilbrands LB, Joosten I. Ex vivo expansion of human CD4+ CD25 high regulatory T cells from transplant recipients permits functional analysis of small blood samples. J Immunol Methods 2006; 314(1-2)103–113
   PubMedGoogle Scholar
• Bluestone JA. Regulatory T-cell therapy: Is it ready for the clinic?. Nat Rev Immunol 2005; 5(4)343–349
   PubMedGoogle Scholar
• Samsom JN. Regulation of antigen-specific regulatory T-cell induction via nasal and oral mucosa. Crit Rev Immunol 2004; 24(3)157–177
   PubMedGoogle Scholar
• Albani S, Prakken B. T cell epitope-specific immune therapy for rheumatic diseases. Arthritis Rheum 2006; 54(1)19–25
   PubMedGoogle Scholar
• Kamphuis S, Kuis W, de Jager W, et al. Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis. Lancet 2005; 366(9479)50–56
   PubMed Web of Science ®Google Scholar